AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
BSX vs MRK Fundamental Comparison
| Metric | BSX | MRK |
|---|---|---|
| Revenue | $20.1B | $65.0B |
| Net Income | $2.9B | $18.3B |
| Net Margin | 14.4% | 28.1% |
| ROE | 12.0% | 34.7% |
| ROA | 6.6% | 13.3% |
| Current Ratio | 1.62x | 1.54x |
| Debt/Equity | 0.46x | 0.89x |
| EPS | $1.94 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs MRK: Frequently Asked Questions
Is BSX or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. BSX is rated BUY (80% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does BSX compare to MRK fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 12.0% vs Merck & Co., Inc.'s 34.7%. Net margins are 14.4% vs 28.1% respectively.
Which stock pays higher dividends, BSX or MRK?
BSX has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or MRK for long term?
For long-term investing, consider that BSX has BUY rating with 80% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs MRK, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.